ATI RN
ATI RN Pharmacology 2023 II Questions
Extract:
Question 1 of 5
A nurse is assessing the vital signs of a client who is taking amiodarone. The nurse should anticipate which of the following findings as an adverse effect of the medication?
Correct Answer: C
Rationale: Bradycardia is a well-known adverse effect of amiodarone. Amiodarone can slow the heart rate significantly, leading to bradycardia, which requires monitoring and potential intervention.
Question 2 of 5
A nurse is preparing to transcribe a prescription for a client that reads 'ondansetron 8 mg by mouth every 12 hr PRN.' Which of the following parts of the prescription should the nurse clarify with the provider?
Correct Answer: D
Rationale: Reason is not specified in the prescription. PRN (as needed) medications should include the specific indication for use to ensure safe and appropriate administration. The nurse should clarify with the provider under what circumstances the ondansetron should be given, such as for nausea or vomiting.
Question 3 of 5
A nurse is planning to administer a prefilled syringe of enoxaparin to a client. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: Administer the medication into the anterolateral or posterolateral abdominal area is correct. Enoxaparin should be administered subcutaneously into the anterolateral or posterolateral abdominal area to ensure proper absorption and minimize complications.
Question 4 of 5
A nurse is developing a teaching plan for an older adult client who has a new prescription for insulin glargine. Which of the following expected outcomes should the nurse include in the plan?
Correct Answer: D
Rationale: The client will wear his reading glasses when drawing up a dose of insulin glargine is an appropriate outcome. Ensuring that the client can accurately measure and administer the correct dose of insulin is crucial for effective diabetes management and preventing dosing errors.
Question 5 of 5
A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?
Correct Answer: B
Rationale: WBC count (White Blood Cell count) is the primary laboratory value to monitor when evaluating the effectiveness of filgrastim. Filgrastim is a granulocyte colony-stimulating factor that promotes the production of neutrophils, a type of white blood cell. An increase in WBC count indicates that the treatment is effective.